Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2010
11/17/2010EP2251338A2 Organic compounds
11/17/2010EP2251335A1 Branched compounds, organic thin films made by using the same, and organic thin film devices
11/17/2010EP2251332A1 The aromatic ring triazine derivatives and the uses thereof
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2251326A1 Heterocyclic compound
11/17/2010EP2251324A1 Heteroaryl-alkylcarbamate compounds and their use as inhibitors of the faah enzyme
11/17/2010EP2250171A2 Antibacterial fluoroquinolone analogs
11/17/2010EP2250170A1 Azaindole compounds for treatment of central nervous system disorders
11/17/2010EP2250169A1 Pyrido [4, 3-d]pyrimidinone derivatives as kinase inhibitors
11/17/2010EP2250162A2 Amide derivatives as positive allosteric modulators and methods of use thereof
11/17/2010EP2249833A1 Prodrugs of cgrp receptor antagonist
11/17/2010EP2249830A1 Dual pharmacophores - pde4-muscarinic antagonistics
11/17/2010EP2249647A1 Dual pharmacophores - pde4-muscarinic antagonistics
11/17/2010EP2249646A1 Dual pharmacophores - pde4-muscarinic antagonistics
11/17/2010EP2097411B1 3 -amino-imidazo [1,2 -a]pyridine derivatives having an sglt1 and sglt2 inhibiting action, for treating type 1 and type 2 diabetes
11/17/2010EP1931680B1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
11/17/2010EP1917264B1 Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/17/2010EP1585522B1 Quinazolinones as potassium channel modulators
11/17/2010EP0773940B2 Process for synthesis of substituted sulphoxides
11/17/2010CN101889014A Enantiomerically enriched imidazoazepinone compounds
11/17/2010CN101889013A Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes
11/17/2010CN101889012A Fungicidal bicyclic pyrazoles
11/17/2010CN101889011A Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3- carboxylic acid amides
11/17/2010CN101889009A Inhibitors of c-fms kinase
11/17/2010CN101889004A Inhibitors of protein kinases
11/17/2010CN101885726A New compound structure and preparation method and application thereof
11/17/2010CN101885725A Pyrro-quinoline quinine sodium salt derivative and preparation method thereof
11/17/2010CN101885722A Heterocycle alkyne and benzene compound, medicinal composition and application thereof
11/17/2010CN101885699A Method for synthesizing chiral polycyclic compounds having butyrolactam skeletons
11/17/2010CN101440092B 2-indazole-4-aza indole-5-amino derivatives, and preparation and use thereof
11/17/2010CN101370497B Combination product with PARP inhibitors and cell toxin and its uses
11/17/2010CN101317844B Application of N-methyl-D-asparagic acid acceptor inhibitor in preparing contraceptive medicament
11/16/2010US7834180 contacting a picolinic acid derivative with a benzothiazole derivative or tautomers thereof, in the presence of a non-nucleophilic base; compounds inhibit cell proliferation, induce cell apoptosis and stabilize a quadruplex structure
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834043 Prevent reproduct of aids virus
11/16/2010US7834028 Pyrazolo-tetrahydro pyridine derivatives as orexin receptor antagonists
11/16/2010US7834027 Gemifloxacin process and polymorphs
11/16/2010US7834008 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
11/16/2010US7833634 employed in an organic compound layer provided between a pair of electrodes in an organic light-emitting device; emits green color or blue color
11/16/2010CA2477474C Cyclic n-substituted alpha imino carboxylic acids for selective inhibition of collagenase
11/16/2010CA2436846C Thioether substituted imidazoquinolines
11/11/2010WO2010129729A1 Substituted spirocyclic amines useful as antidiabetic compounds
11/11/2010WO2010129668A1 Pyrazolopyridines
11/11/2010WO2010129620A1 Imidazo [ 1, 2 -a] pyridin-2 -yl-phenyl derivatives to be used in cancer treatment
11/11/2010WO2010129570A1 Solid forms of sulfonamides and amino acids
11/11/2010WO2010129567A1 Pyrrolo [2, 3. b] pyridines which inhibit raf protein kinase
11/11/2010WO2010128995A1 Phenoxymethyl heterocyclic compounds
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010128595A1 Method for producing radioactive iodine-labeled imidazopyridine derivative
11/11/2010WO2010128425A1 Gpr 119 modulators
11/11/2010WO2010128414A1 Gpr 119 modulators
11/11/2010WO2010128058A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010WO2010127754A1 3-([1,2,3]triazole-4-yl)-pyrrolo[2,3-b]pyridine derivates
11/11/2010WO2010127575A1 One-step synthesis method of 2,9-dimethyl-4,7-diphenyl-1,10- phenanthroline
11/11/2010WO2010127574A1 One-step synthesis method of symmetrical 1,10- phenanthroline derivative
11/11/2010WO2010092015A8 Urea triazolo [1, 5-a] pyridine derivatives as pi3k inhibitors
11/11/2010WO2009155403A3 Processes for the preparation of varenicline and intermediates thereof
11/11/2010WO2009009001A9 Crystalline pyridazine compound
11/11/2010US20100286396 Novel isoquinoline derivatives
11/11/2010US20100286191 2-Arylthiazole Derivatives as CXCR3 Receptor Modulators
11/11/2010US20100286190 Certain substituted ureas, as modulators of kinase activity
11/11/2010US20100286189 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
11/11/2010US20100286188 Means for improving cognitive functions and memory based on hydrogenated pyrido(4,3-b)indoles (variants), pharmacological means based thereon and method for the use thereof
11/11/2010US20100286182 Hydrazide compounds as thyroid hormone receptor modulators and uses thereof
11/11/2010US20100286178 Compounds and uses thereof
11/11/2010US20100286163 Indolo[3,2-c]quinoline compounds
11/11/2010US20100286151 1-OXA-3-Azaspiro[4,5]Decan--2-One Derivatives For The Treatment Of Eating Disorders
11/11/2010US20100286144 Heteroaryl derivatives
11/11/2010US20100286142 Compounds and Methods for Kinase Modulation, and Indications Therefor
11/11/2010US20100286123 Inhibitors of the renal outer medullary potassium channel
11/11/2010US20100286113 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
11/11/2010US20100286073 Compounds and methods for pharmaceutical use
11/11/2010US20100285145 Gpr 119 modulators
11/11/2010DE102009019962A1 3-([1,2,3]Triazol-4-yl)-pyrrolo[2,3-b]pyridinderivate 3 - ([1,2,3] triazol-4-yl) pyrrolo [2,3-b] pyridine
11/11/2010CA2761032A1 Phenoxymethyl heterocyclic compounds
11/11/2010CA2760844A1 3-(1,2,3-triazol-4-yl)pyrrolo[2,3-b]pyridine derivatives
11/11/2010CA2760705A1 Pyrazolopyridines
11/11/2010CA2760343A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010CA2760061A1 Diamino heterocyclic carboxamide compound
11/11/2010CA2759997A1 Pyrrolo [2, 3. b] pyridines which inhibit raf protein kinase
11/11/2010CA2759891A1 Gpr 119 modulators
11/11/2010CA2759651A1 Substituted spirocyclic amines useful as antidiabetic compounds
11/10/2010EP2247589A1 7-azaindole derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
11/10/2010EP2247588A2 Fused heterocyclic derivative and use thereof
11/10/2010EP2247586A1 2-aza-bicyclo[2.2.1]heptane derivatives
11/10/2010EP2247292A1 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
11/10/2010EP2247184A1 Dual pharmacophores-pde4-muscarinic antagonistics
11/10/2010EP1957492B1 Substituted bicyclic pyrimidone derivatives
11/10/2010EP1888582B1 Imidazo- and triazolopyridines as inhibitors of 11-beta hydroxysteroid dehydrogenase type i
11/10/2010EP1742944B1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
11/10/2010CN101883772A Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
11/10/2010CN101883768A Oxazolidinone derivative having 7-membered hetero ring
11/10/2010CN101880280A Bicyclic pyrimidinones and uses thereof
11/10/2010CN101880279A One-step synthetic method of symmetrical 1,10-phenanthroline derivatives
11/10/2010CN101880278A One-step method for synthesizing 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101880276A Substituted diazepan compounds as orexin receptor antagonists
11/10/2010CN101245066B Method for producing 7-alkoxyl-2, 9-diazafluorene
11/10/2010CA2759843A1 Gpr 119 modulators
11/09/2010US7829699 efficient synthesis for the preparation of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1 -carboxamide; salt formation of potassium salt forms; treating migraine and cluster headache
1 ... 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 ... 646